Sign in

Balance Sheet - Bioventus Inc. (BVS)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13
Total cash and short-term investments + 51.24 41.58 36.96 30.19 43.93 106.22 64.52 42.77 0.00 0.00 4.95 15.77 0.00
Accounts receivable, net 128.30 127.39 122.79 136.30 124.96 88.28 85.13 73.04 54.51 47.08
Inventories 82.24 92.48 91.33 84.77 61.69 29.12 27.33 27.40 35.18 26.67
Other current assets 11.07 14.16 16.91 21.33 32.52 7.55 6.06 5.14 4.79 5.71
Total current assets 272.84 275.61 268.00 272.58 263.10 211.79 183.03 148.35 99.43 95.23
Total non-current assets + 410.72 452.35 542.91 1,100.07 962.76 282.67 289.37 294.37 387.93 335.19
Total assets 683.56 727.96 810.91 1,372.65 1,225.86 494.47 472.41 442.72 487.35 430.42
Total current liabilities + 160.38 210.40 175.50 304.02 180.86 122.59 89.02 65.43 87.69 52.16
Total non-current liabilities + 294.73 331.95 414.30 656.41 511.21 227.72 237.78 232.03 207.32 200.78
Total liabilities 455.11 542.35 589.79 960.43 692.07 350.31 326.79 297.46 295.01 252.93
Total stockholders' equity + 184.11 147.94 173.59 325.24 458.92 142.24 142.98 145.27 192.34 177.49
Common shares outstanding 69 65 63 61 45 38 57 57 57 57 56 56 56
Show Quarterly Balance Sheet

Balance Sheet - Bioventus Inc. (BVS)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Mar-16 Mar-15
Total cash and short-term investments + 35.85 51.24 42.16 32.91 22.80 41.58 43.07 31.99 25.17 36.96 26.83 29.39 47.10 30.20 34.36 41.00 27.37 43.93 80.92 155.55 143.63 106.22 72.48 126.24 64.52 193.56 0.00 0.00 0.00 6.17 0.00
Accounts receivable, net 120.53 128.30 130.40 132.37 118.08 127.39 121.93 137.31 125.54 122.79 112.90 119.64 118.54 136.30 132.19 143.02 119.29 124.96 105.44 102.03 89.47 88.28 80.81 67.35 67.35 85.13 51.11
Inventories 83.19 82.24 96.27 96.47 94.05 92.48 90.03 87.61 97.01 91.33 97.56 96.28 87.95 84.77 76.95 69.08 64.69 61.69 36.57 34.02 39.81 29.12 34.71 33.76 33.76 27.33 37.12
Other current assets 10.26 11.07 12.06 13.46 14.44 14.16 43.66 51.98 18.18 16.91 12.16 15.34 55.07 21.33 27.59 24.06 34.04 32.52 23.15 17.95 17.19 7.55 5.15 7.06 7.06 6.06 5.59
Total current assets 249.81 272.84 280.90 275.20 249.37 275.61 298.69 308.88 265.90 268.00 249.45 260.64 308.66 272.58 271.08 277.16 245.40 263.10 246.08 290.06 270.72 211.79 193.14 234.41 64.52 183.03 99.99
Total non-current assets + 400.73 410.72 420.69 431.59 442.05 452.35 470.80 483.29 528.34 542.91 561.65 576.32 578.74 1,100.07 1,126.94 931.62 951.74 962.76 408.71 356.58 372.35 282.67 286.14 275.01 -64.52 289.37 386.28
Total assets 650.54 683.56 701.59 706.79 691.41 727.96 769.49 792.17 794.24 810.91 811.10 836.96 887.40 1,372.65 1,398.02 1,208.78 1,197.14 1,225.86 654.79 646.64 643.08 494.47 479.28 509.42 509.42 472.41 486.26
Total current liabilities + 148.10 160.38 161.75 185.68 174.75 210.40 211.49 231.46 173.32 175.50 160.84 179.10 196.06 304.02 288.37 198.87 171.52 180.86 160.71 158.19 149.03 122.59 111.73 97.21 97.21 89.02 86.80
Total non-current liabilities + 268.18 294.73 332.59 319.81 331.18 331.95 371.17 371.65 403.49 414.30 423.81 424.52 450.98 656.41 730.50 489.71 503.70 511.21 263.59 269.09 273.77 227.72 222.20 270.41 270.41 237.78 213.16
Total liabilities 416.27 455.11 494.34 505.49 505.94 542.35 582.66 603.11 576.81 589.79 584.65 603.62 647.04 960.43 1,018.88 688.59 675.22 692.07 424.29 427.27 422.79 350.31 333.94 367.63 367.63 326.79 299.96
Total stockholders' equity + 188.90 184.11 166.10 161.24 148.14 147.94 148.74 150.94 171.28 173.59 177.53 183.20 188.51 325.24 343.40 447.98 449.78 458.92 152.50 141.56 142.39 142.24 143.22 139.18 145.62 142.98 186.30
Common shares outstanding 70 69 69 69 66 65 65 64 63 63 63 63 62 62 62 61 60 55 42 42 42 38 56 56 56 57 56 56 56 56 57
5 days ago